Foresee Pharmaceuticals (Taiwan) Probability of Future Stock Price Finishing Over 77.0
| 6576 Stock | TWD 78.50 1.50 1.95% |
Foresee |
Foresee Pharmaceuticals Target Price Odds to finish over 77.0
The tendency of Foresee Stock price to converge on an average value over time is a known aspect in finance that investors have used since the beginning of the stock market for forecasting. However, many studies suggest that some traded equity instruments are consistently mispriced before traders' demand and supply correct the spread. One possible conclusion to this anomaly is that these stocks have additional risk, for which investors demand compensation in the form of extra returns.
| Current Price | Horizon | Target Price | Odds to stay above NT$ 77.00 in 90 days |
| 78.50 | 90 days | 77.00 | about 86.21 |
Based on a normal probability distribution, the odds of Foresee Pharmaceuticals to stay above NT$ 77.00 in 90 days from now is about 86.21 (This Foresee Pharmaceuticals Co probability density function shows the probability of Foresee Stock to fall within a particular range of prices over 90 days) . Probability of Foresee Pharmaceuticals price to stay between NT$ 77.00 and its current price of NT$78.5 at the end of the 90-day period is about 21.32 .
Assuming the 90 days trading horizon Foresee Pharmaceuticals Co has a beta of -0.0261. This suggests as returns on the benchmark increase, returns on holding Foresee Pharmaceuticals are expected to decrease at a much lower rate. During a bear market, however, Foresee Pharmaceuticals Co is likely to outperform the market. Additionally Foresee Pharmaceuticals Co has a negative alpha, implying that the risk taken by holding this instrument is not justified. The company is significantly underperforming the Dow Jones Industrial. Foresee Pharmaceuticals Price Density |
| Price |
Predictive Modules for Foresee Pharmaceuticals
There are currently many different techniques concerning forecasting the market as a whole, as well as predicting future values of individual securities such as Foresee Pharmaceuticals. Regardless of method or technology, however, to accurately forecast the stock market is more a matter of luck rather than a particular technique. Nevertheless, trying to predict the stock market accurately is still an essential part of the overall investment decision process. Using different forecasting techniques and comparing the results might improve your chances of accuracy even though unexpected events may often change the market sentiment and impact your forecasting results.Foresee Pharmaceuticals Risk Indicators
For the most part, the last 10-20 years have been a very volatile time for the stock market. Foresee Pharmaceuticals is not an exception. The market had few large corrections towards the Foresee Pharmaceuticals' value, including both sudden drops in prices as well as massive rallies. These swings have made and broken many portfolios. An investor can limit the violent swings in their portfolio by implementing a hedging strategy designed to limit downside losses. If you hold Foresee Pharmaceuticals Co, one way to have your portfolio be protected is to always look up for changing volatility and market elasticity of Foresee Pharmaceuticals within the framework of very fundamental risk indicators.α | Alpha over Dow Jones | -0.07 | |
β | Beta against Dow Jones | -0.03 | |
σ | Overall volatility | 2.12 | |
Ir | Information ratio | -0.15 |
Foresee Pharmaceuticals Alerts and Suggestions
In today's market, stock alerts give investors the competitive edge they need to time the market and increase returns. Checking the ongoing alerts of Foresee Pharmaceuticals for significant developments is a great way to find new opportunities for your next move. Suggestions and notifications for Foresee Pharmaceuticals can help investors quickly react to important events or material changes in technical or fundamental conditions and significant headlines that can affect investment decisions.| Foresee Pharmaceuticals generated a negative expected return over the last 90 days | |
| The company reported the revenue of 226.03 M. Net Loss for the year was (569.27 M) with profit before overhead, payroll, taxes, and interest of 175.08 M. | |
| Foresee Pharmaceuticals Co has accumulated about 1.34 B in cash with (213.33 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 11.47. | |
| Roughly 35.0% of the company shares are owned by insiders or employees |
Foresee Pharmaceuticals Price Density Drivers
Market volatility will typically increase when nervous long traders begin to feel the short-sellers pressure to drive the market lower. The future price of Foresee Stock often depends not only on the future outlook of the current and potential Foresee Pharmaceuticals' investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. Foresee Pharmaceuticals' indicators that are reflective of the short sentiment are summarized in the table below.
| Common Stock Shares Outstanding | 117.6 M |
Foresee Pharmaceuticals Technical Analysis
Foresee Pharmaceuticals' future price can be derived by breaking down and analyzing its technical indicators over time. Foresee Stock technical analysis helps investors analyze different prices and returns patterns as well as diagnose historical swings to determine the real value of Foresee Pharmaceuticals Co. In general, you should focus on analyzing Foresee Stock price patterns and their correlations with different microeconomic environments and drivers.
Foresee Pharmaceuticals Predictive Forecast Models
Foresee Pharmaceuticals' time-series forecasting models is one of many Foresee Pharmaceuticals' stock analysis techniques aimed to predict future share value based on previously observed values. Time-series forecasting models are widely used for non-stationary data. Non-stationary data are called the data whose statistical properties, e.g., the mean and standard deviation, are not constant over time, but instead, these metrics vary over time. This non-stationary Foresee Pharmaceuticals' historical data is usually called time series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the stock market movement and maximize returns from investment trading.
Things to note about Foresee Pharmaceuticals
Checking the ongoing alerts about Foresee Pharmaceuticals for important developments is a great way to find new opportunities for your next move. Our stock alerts and notifications screener for Foresee Pharmaceuticals help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.
| Foresee Pharmaceuticals generated a negative expected return over the last 90 days | |
| The company reported the revenue of 226.03 M. Net Loss for the year was (569.27 M) with profit before overhead, payroll, taxes, and interest of 175.08 M. | |
| Foresee Pharmaceuticals Co has accumulated about 1.34 B in cash with (213.33 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 11.47. | |
| Roughly 35.0% of the company shares are owned by insiders or employees |
Additional Tools for Foresee Stock Analysis
When running Foresee Pharmaceuticals' price analysis, check to measure Foresee Pharmaceuticals' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Foresee Pharmaceuticals is operating at the current time. Most of Foresee Pharmaceuticals' value examination focuses on studying past and present price action to predict the probability of Foresee Pharmaceuticals' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Foresee Pharmaceuticals' price. Additionally, you may evaluate how the addition of Foresee Pharmaceuticals to your portfolios can decrease your overall portfolio volatility.